American Airlines Cargo Builds Pharmaceutical Handling Facility - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

American Airlines Cargo Builds Pharmaceutical Handling Facility


American Airlines Cargo has started construction on a pharmaceutical handling facility in Philadelphia, PA. 

The 25,000-sq-ft facility is designed for a range of temperature-sensitive products being shipped in and out of the Northeast pharmaceutical corridor of the United States

Included within the new building will be 6000 sq-ft for controlled room temperature (CRT) passive shipments at +15 C and +25 C. A 3000-sq-ft refrigerated area will be available for shipments that need to be maintained in a +2 C to +8 C environment. A deep frozen area will be available for shipments that need to be kept at -10 C to -20 C, with powered charging stations for up to 30 electronically controlled units.

The facility is expected to be completed in the fall and will be equipped with technology to monitor products with proactive alarming and will be validated to 0.25°C. Back up power generation is designed to ensure product protection in the event of a power failure, the company reports.

The opening of the Philadelphia pharmaceutical facility will coincide with the rollout of a ExpediteTC cold chain program across the American Airlines network.

Source: American Airlines Cargo

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here